Eukaryotic translation initiation factor 3 subunit C is associated with acquired resistance to erlotinib in non-small cell lung cancer.
Shintani T, Higashisaka K, Maeda M, Hamada M, Tsuji R, Kurihara K, Kashiwagi Y, Sato A, Obana M, Yamamoto A, Kawasaki K, Lin Y, Kijima T, Kinehara Y, Miwa Y, Maeda S, Morii E, Kumanogoh A, Tsutsumi Y, Nagatomo I, Fujio Y.
Shintani T, et al. Among authors: yamamoto a.
Oncotarget. 2018 Dec 25;9(101):37520-37533. doi: 10.18632/oncotarget.26494. eCollection 2018 Dec 25.
Oncotarget. 2018.
PMID: 30680067
Free PMC article.